Navigation Links
Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBC's 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
Date:5/7/2008

Presenters include David M. Mott from MedImmune Inc., Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company, Federico Goodsaid, Ph.D from the

FDA, and Mark Ratner from FDC_Windhover

WESTBOROUGH, Mass., May 7 /PRNewswire/ -- IBC Life Sciences announced the keynote line up for the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress, to take place August 4-7, 2008 in Boston, MA. The keynote presentations will include speakers David M. Mott from MedImmune Inc. and Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company. Keynote panel discussions this year will be led by Federico Goodsaid, Ph.D from the FDA, and Mark Ratner from FDC Windhover.

The two individual keynote speakers will discuss the scientific and business strategies that are necessary to move to clinical POC quickly. Keynote panel discussions will approach the more "controversial" topics such as the FDA position on biomarkers and the impact of the 2008 elections on the future of the pharmaceutical/healthcare industry. Presentations include:

4:20 PM, Tuesday, August 5:

Keynote speaker David M. Mott, Chief Executive Officer and President, MedImmune, Inc. will present "Risk-Taking & Innovation in Biotechnology: The MedImmune Success Story."

5:00 PM, Tuesday, August 5:

Keynote panel discussion "Biomarker Qualification in Drug Development: A Regulatory/Industry Discussion" will be led by Federico Goodsaid, Ph.D., Associate Director for Operations in Genomics, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.

11:20 AM, Wednesday, August 6:

Keynote speaker Elliott Sigal, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Research & Development, Bristol-Myers Squibb Company will discuss "BioPharma of the Future: Blending the Best to Create the Next."

12:00 PM, Wednesday, August 6:

Keynote panel discussion "Leading in a Sea of
'/>"/>

SOURCE IBC Life Sciences
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. New TUMS(R) QuikPak(TM) Campaign Offers Innovative Heartburn Relief with a Little Help from the Jetsons
2. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
3. Sigma(R) Launches Innovative ChIP Kit Technology For Epigenetic Research
4. Bon MOT: Innovative atom trap catches highly magnetic atoms
5. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
6. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
7. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
8. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
9. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
10. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
11. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , HUNTINGTON BEACH, California and AMST... leader in molecular cancer diagnostics, announced...care administrator, has established,coding guideli...is Agendia,s,FDA-cleared breast cancer recurrence ...08. , Patients across the United States c...
(Date:12/1/2009)..., NEW YORK and MONTREAL, Dec. 1 /PRNewswire-First... -ICBS Ltd. (OTCPK: ICBT), announced today that th...ufacturing Inc., of Canada for the manufacturing o...bution in the U.S. ,, "We have seen the disastr...sh vegetables and packaged salads in the past" sai...
(Date:12/1/2009)... The two humanitarian organizatio...rams, including biomedical repair technologies. Th...he West African country of Togo. , ...ith the recent signing of a Memorandum of Understa... formalized a partnership to help develop sustaina...
(Date:11/30/2009)..., COLUMBUS, Ohio, Nov. 30 The O... one of the nation,s first minority business early...Cleveland December 3, is called "Transforming the ...ess Early-Stage Capital Summit." It will feature s...rity business leaders and local minority entrepren...
Breaking Biology Technology:Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
...GO, June 2 Alternative Reproductive Resources,(AR...ether intended,parents, egg donors and surrogate m... some of the pressure from the egg donor selection...fers intended parents, for a,nominal fee, "first c...iod.,This means that participants have that window...
...ionLine adds high-end exploratory/translational me...psychopharmacology expertise; supports Kendle s...hase business, CINCINNATI, June 2 Kendle (Nasdaq...research organization (CRO), today,announced the a...ration,(DecisionLine Clinical Services), a private...
...QUAN, N.J., June 2 BioSpace, the world,s leading,...r fair company, revealed,this morning the 2008 Bio...ustry in Delaware, Maryland, Virginia and Washingt.../prnh/20080602/CLM086 ), This Hotbed Campaign fe...e biotechnology, pharmaceutical and medical device...
Other Biology Technology:ARR Offers Parents 'Extended Choice' in Egg Donor Selections 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 3Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 4Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 5BioSpace Releases the 2008 BioCapital(TM) Hotbed Campaign 2
(Date:11/30/2009)...ersity of Pittsburgh team overcame a major hurdle ...those that could lead to more efficient catalysts ...ss toxic. The researchers reported Nov. 29 in Nat...perature stability in metallic nanoparticles, the ...lnerability to extreme heat. , Gtz Veser, an ass...
(Date:11/30/2009)... The inaugural Global Conference on Systems & Ente...Washington, DC, focuses on the convergence of comp...l importance to society. , The goal of the c...vity around targeted complex systems, examined by ...ncludes Critical Infrastructure Systems, including...
(Date:11/30/2009)...ght the stress of seeing your extended family over...w research report in the December 2009 print issue...w.jleukbio.org ) shows that you might be right. He...ght lead to entirely new treatments that help keep...zema under control. That,s because researchers fro...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 1Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 2Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 1Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 2Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 3The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 1The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 2The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 3The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 4The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 5The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 6The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 7The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 8The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 9The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 10The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 11The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 12The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 13The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 14The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 15The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 16
...re resulting from dilated cardiomyopathy is rapidl...Molecular mechanisms are being studied and advance... familial forms. Intracellular [Ca2+]i homeostasis...grity, and dysregulation of [Ca2+]i is a hallmark ...r cardiac [Ca2+]i transients is calcium entry thro...
...nts with type 2 diabetes (DT2) has been elucidated... chip technologies allowing 400,000 DNA mutations ... a predisposition to DT2 have been identified. The...in-secreting cells (ZnT8), which is a potential ta...ation was carried out as a French-British-Canadian...
...e ban on smoking in Ireland resulted in an 83 perc...ent decrease in airborne carcinogens for patrons a...alth of bar workers, according to a one-year follo...ssue for April 2007 of the American Journal of Res...the American Thoracic Society. , Luke Clancy, M...
Other Biology News:Protein overexpression at heart of heart failure 2Elucidation of the genome for diabetics with DNA chips 2Elucidation of the genome for diabetics with DNA chips 3Smoking ban dramatically reduces air pollution in Irish pubs 2Smoking ban dramatically reduces air pollution in Irish pubs 3
Rabbit Anti-TetR Polyclonal Antibody, Unconjugated from Abcam
Syrian Hamster Anti-Mouse Ly-49C / F / I / H Monoclonal Antibody, Biotin Conjugated, Clone 14B11 from BioLegend
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Biology Products: